[1]
Sirirungsri, W. 2015. Serious Adverse Events Attributed to Nevirapine Regimens for Postexponsure Prophylaxis After HIV Exposures-Worldwide, 1997-2000. Journal of Associated Medical Sciences. 34, 2 (Feb. 2015), 131.